Cephalothin and Cefazolin in Vitro Antibacterial Activity and Pharmacokinetics in Dogs
Overview
Veterinary Medicine
Authors
Affiliations
The periods of time that cephalothin and cefazolin serum concentration remained above minimum inhibitory concentration (MIC) for beta hemolytic, coagulase positive staphylococcal, and Escherichia coli clinical isolates were compared. Cephalothin and cefazolin were similarly very effective in vitro against staphylococcal isolates, with an MIC90 of 0.12 microgram/mL and 0.25 microgram/mL, respectively. In contrast, cefazolin was more effective than cephalothin against E coli isolates; the cefazolin MIC90 for E coli was 16 micrograms/mL and for cephalothin 64 micrograms/mL. Cefazolin (20 mg/kg intravenously [i.v.]) serum concentration remained more than MIC90 for E coli isolates significantly longer than serum concentration of cephalothin (40 mg/kg i.v.) (P < .001).
Tirumalai M, Karouia F, Tran Q, Stepanov V, Bruce R, Ott C mBio. 2019; 10(1).
PMID: 30647159 PMC: 6336426. DOI: 10.1128/mBio.02637-18.
Cagnardi P, Di Cesare F, Toutain P, Bousquet-Melou A, Ravasio G, Villa R Front Pharmacol. 2018; 9:1137.
PMID: 30356800 PMC: 6190795. DOI: 10.3389/fphar.2018.01137.
Papich M, Lindeman C J Vet Diagn Invest. 2017; 30(1):113-120.
PMID: 29145786 PMC: 6504153. DOI: 10.1177/1040638717742434.
Cefazolin pharmacokinetics in cats under surgical conditions.
Albarellos G, Montoya L, Passini S, Lupi M, Lorenzini P, Landoni M J Feline Med Surg. 2016; 19(10):992-997.
PMID: 27609113 PMC: 11110984. DOI: 10.1177/1098612X16666594.
Lagneau F, Marty J, Beyne P, Tod M J Pharmacokinet Pharmacodyn. 2005; 32(1):1-32.
PMID: 16175313 DOI: 10.1007/s10928-005-2101-0.